Ledger.Open graph →
SEC Form D · filed February 17, 2023

Quanta Therapeutics, Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Cameron Pitt · San Francisco, CAExec · DirectorMaha Katabi · San Francisco, CADirectorArjun Goyal · San Francisco, CADirectorSamuel Saks · San Francisco, CADirectorLeonardo Faoro · San Francisco, CAExecYing Huang · San Francisco, CADirectorPerry Nisen · San Francisco, CAExec · DirectorMaria Fardis · San Francisco, CADirectorDan O'Brien · Cascais, S1DirectorJoseph B. Rotberg · New York, NYDirectorMark A. Mauceri · New York, NYExec · DirectorBenjamin A. Hochberg · New York, NYDirectorChristian B. Chauvet · New York, NYExec · DirectorHui Chen · New York, NYDirectorKatherine Simon · Los Angeles, CADirectorApril Stephenson · Los Angeles, CAExecKenneth A. Harris · Kenilworth, ILDirectorJill A. Bommarito · Shelby Township, MIExec · DirectorTanya J. Campbell · Grand Cayman, Cayman IslandsDirectorRavi Gullapalli · Southlake, TXExec · DirectorRobert Lyons · Grand Cayman, Cayman IslandsDirectorFred D. Clark · Fern Park, FLExecAaron Dillon · NEW YORK, NYDirectorDavid Barker · Fern Park, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗